← Eichor
Study identifier: NCT07622199 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

PROfunda Femoris Vein Thrombosis Evaluation and Clearance to Improve Outcomes of Endovascular Treatment for Acute Iliofemoral Deep Vein Thrombosis

Condition: Deep Vein Thrombosis  ·  Sponsor: RenJi Hospital

PhaseNA
Planned participants140
Who can joinAll sexes, 18 Years to 85 Years
Healthy volunteersNo

About this study

Patients with iliofemoral vein thrombosis are prone to developing post-thrombotic syndrome (PTS). The profunda femoris vein (PFV) is an important inflow of the iliofemoral vein. Profunda femoris vein thrombosis clearance (PFV-TC) may improve the patency of iliofemoral vein and reduce the occurrence of PTS.

This description comes directly from the study's public registry record.

Talk to the study team

Qihong Ni  ·  +8615801900772  ·  niqihong1989@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Renji hospitalShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07622199